Navigation Links
Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Date:12/7/2012

tion and enhances insulin secretion, that confirmed the activity we observed in our preclinical studies," continued Dr. Bhanot.  "Given the unique mechanism of action and potentially favorable safety profile observed in the Phase 1 study, we believe that ISIS-GCGRRx could be valuable for diabetic patients with severe hyperglycemia who are not controlled with current treatments by not only controlling glucose, but also preserving pancreatic function, which would enhance endogenous insulin activity."

ISIS-GCCRRx
ISIS-GCCRRx targets the glucocorticoid receptor (GCCR) and is designed to reduce the effects of glucocorticoids, hormones that promote liver glucose production and fat storage in the liver and fat tissues.  Because excessive GCCR activity in the liver and fat is associated with obesity, insulin resistance and glucose intolerance, ISIS-GCCRRx has the potential to improve glycemic and lipid control in patients with type 2 diabetes.  "Reduction of GCCR in tissues other than the liver and fat, such as the brain, can result in many unwanted and potentially toxic side effects, as has been reported with small molecule inhibitors of GCCR.  Because ISIS-GCCRRx reduces GCCR activity only in liver and fat tissues, we avoid these unwanted side effects.  In preclinical studies, we demonstrated that antisense reduction of GCCR was limited to the liver and fat tissues and produced robust lowering of glucose and lipid levels.  Results from our ISIS-GCCRRx Phase 1 study were consistent with the liver- and fat-specific activity we observed in our preclinical studies, and also provided early encouraging data on the drug's therapeutic activity," concluded Dr. Bhanot.  "Given the mechanism of action, we believe that ISIS-GCCRRx could be particularly useful for diabetic patients with moderate to severe hyperglycemia who are also obese or have high levels of ch
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
3. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
4. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
5. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
6. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
7. Salix Pharmaceuticals Donates $500,000 To ASGEs IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
8. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
9. Double-digit Growth Rate of the Pharmaceuticals Industry in Asia Pacific Boosts the API Market, Finds Frost & Sullivan
10. Cadence Pharmaceuticals to Host Analyst and Investor Day
11. Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... Although colonoscopy exams prevent many colon cancer ... method for detecting colorectal cancers 2 , the procedure ... . EndoChoice ® Inc. today unveiled research that ... accuracy of this procedure and greatly reduces the number ... these clinical trial results and featuring the Fuse system ...
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. ... of protective clothing for industry, healthcare and to first ... release its financial results for the fiscal 2013 fourth ... May 21, 2013 at stock market close and will ... 4:30 p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ...
(Date:5/17/2013)... -- Sony Biotechnology Inc. ("Sony") today announced the launch of the ... chip.  Sony will also be exhibiting its newly rebranded reagent ... the EC800 flow cytometer, and new SP6800 Spectral Analyzer will ... be held at the San Diego ... from May 20 - 22.  The 8-well ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Sony Delivers New Technology for Science to CYTO 2013 2
... , NEW YORK ... Kantar Health , a leading healthcare-focused consultancy and ... in tracking and evaluating pharmaceutical promotion on the prescribing behavior ... and Regimens, a timely, robust tool to assess oncology drug ...
... , PRINCETON, N.J. , Feb. 2 ... the Company), a late-stage biotechnology company, announced today the publication ... of Vaccine, which describes preclinical formulations of RiVax™, ... authored by the Company,s collaborators at the University of ...
Cached Medicine Technology:Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions 2Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions 3Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions 4Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 2Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 3Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 4Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 5Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 6Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 7
(Date:5/19/2013)... Healthcare leaders will gather at the ... Walt Disney World Swan and Dolphin in Orlando, Fla., ... care delivery and healthcare reform and implementation. , “Reform ... markets, with consolidation, efficiency and reduced payments ... Ebert, Amerinet president and CEO. “There is a real ...
(Date:5/19/2013)... New York (PRWEB) May 19, 2013 ... in a federal litigation now underway in U.S. District ... Case Management Order dated May 3rd, the Court has ... Nominee Pool to eight cases rather than four. The ... scheduled for Thursday, May 23rd. (In re: Actos Product ...
(Date:5/19/2013)... According to a new market ... (2013 – 2018): By Applications (Healthcare (Endoscopy, Radiology, ... CMOS, Contact IS, Infrared, X-Ray) And Geography" published ... was $8.00 billion in 2012 and is expected ... estimated CAGR of 3.84% from 2013 to 2018. ...
(Date:5/19/2013)... May 19, 2013 Fat Burning Furnace ... program that provides people with fat burning diet ... order this Fat Burning Furnace package, people will receive ... they can download quickly. The Fat Burning Furnace manual ... people build lean muscle mass. In addition, this book ...
(Date:5/19/2013)... Dr. Keith Chertok now provides gum disease ... gums and increase the chance of a healthier smile. ... Procedure (LANAP) not only removes diseased gum tissue in patients, ... bone for dental implants. , LANAP uses a ... can also help stimulate the healthy tissue as well as ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2
... ... ... Golding is an avid cyclist and a man with a dream. His dream was ... programmer, it seemed Mr. Golding,s dream would never stand a chance competing with a multitude ...
... What,s the most effective way to convince young women to ... their risk of melanoma, the deadliest form of skin cancer, ... wrinkled skin. "They,re not worried about skin cancer, ... said June Robinson, a professor of dermatology at Northwestern University ...
... and inner-ear disorders, and Johns Hopkins University,s provost and ... the Prosper Mnire Society,s 2010 gold medal. The ... basis of Mnire,s disease, named for the French scientist ... "constant ringing noise in the head," or so-called tinnitus, ...
... difference, but others call this risky , MONDAY, May 17 ... not spread beyond the gland doesn,t make much difference in ... , "One thing that really surprised me was how good ... report on the study, published in the May issue of ...
... drugs in euthanasia and in cases without explicit ... according to a study in CMAJ ... . Euthanasia is legal in Belgium if ... care, one of which is that they discuss ...
... ... Records and Health Information Exchange , ... McHenry County, IL (Vocus) May 17, 2010 -- Centegra ... a health information technology sharing program that creates the region’s first-ever Health Information Exchange ...
Cached Medicine News:Health News:Former Microsoft Employee Combines Passion For Technology With American Made Chris King Bicycle Parts 2Health News:Former Microsoft Employee Combines Passion For Technology With American Made Chris King Bicycle Parts 3Health News:Wrinkles are scarier than skin cancer for young tanners 2Health News:Wrinkles are scarier than skin cancer for young tanners 3Health News:Johns Hopkins provost honored with international award 2Health News:Experts Divided on Whether to Treat Thyroid Cancer 2Health News:Experts Divided on Whether to Treat Thyroid Cancer 3Health News:The role of nurses in physician-assisted dying 2Health News:Centegra Health System Launches New Physician Network 2Health News:Centegra Health System Launches New Physician Network 3
... aspirator is intended for destruction and removal ... operative interventions in the field of a ... In an operational zone in a consequence ... with liquid environment interaction arises cavitational processes. ...
... Dissectron ultrasonic aspirator, portable ... surgical aspirator for the ... tissue available only outside ... in a very compact ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Medicine Products: